Feedback / Questions
vobramitamab duocarmazine (MGC018) - MacroGenics
https://www.globenewswire.com/news-release/2024/03/07/2842713/0/en/MacroGenics-Provides-Update-on-Corporate-Progress-and-2023-Financial-Results.html
Mar 7, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next